Impact Analytical Expands Michigan Facility - Pharmaceutical Technology

Latest Issue
PharmTech

Latest Issue
PharmTech Europe

Impact Analytical Expands Michigan Facility



Impact Analytical’s new facility, located in Midland, Mich., has added $200,000 in instrumentation and brought on several additional analytical and business development experts to support its testing services since its opening in June 2013.

The new instrumentation gives Impact the opportunity to strengthen its core capabilities, including ICP-MS to comply with new USP methods (<232> and <233>) for heavy metals, ion chromatography, an ASE extractor for use in extractables and leachables studies, and a LC-MS Q-TOF system with exact mass capabilities.

The new site includes 35 scientists who operate more than 80 instruments in six areas, including elemental analysis, gas separation, liquid separation, microscopy, molecular characterization, and thermal and mechanical properties.

Source: Impact Analytical

ADVERTISEMENT

blog comments powered by Disqus
LCGC E-mail Newsletters

Subscribe: Click to learn more about the newsletter
| Weekly
| Monthly
|Monthly
| Weekly

Survey
What role should the US government play in the current Ebola outbreak?
Finance development of drugs to treat/prevent disease.
Oversee medical treatment of patients in the US.
Provide treatment for patients globally.
All of the above.
No government involvement in patient treatment or drug development.
Finance development of drugs to treat/prevent disease.
29%
Oversee medical treatment of patients in the US.
11%
Provide treatment for patients globally.
7%
All of the above.
46%
No government involvement in patient treatment or drug development.
7%
Jim Miller Outsourcing Outlook Jim MillerCMO Industry Thins Out
Cynthia Challener, PhD Ingredients Insider Cynthia ChallenerFluorination Remains Key Challenge in API Synthesis
Marilyn E. Morris Guest EditorialMarilyn E. MorrisBolstering Graduate Education and Research Programs
Jill Wechsler Regulatory Watch Jill Wechsler Biopharma Manufacturers Respond to Ebola Crisis
Sean Milmo European Regulatory WatchSean MilmoHarmonizing Marketing Approval of Generic Drugs in Europe
Legislators Urge Added Incentives for Ebola Drug Development
FDA Reorganization to Promote Drug Quality
FDA Readies Quality Metrics Measures
New FDA Team to Spur Modern Drug Manufacturing
From Generics to Supergenerics

Click here